{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:42:57Z","timestamp":1787168577084,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872484"],"award-info":[{"award-number":["81872484"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Social Development Fund of Jiangsu Province","award":["BE2019605"],"award-info":[{"award-number":["BE2019605"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02444-0","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:48:44Z","timestamp":1762166924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Blocking CCR1+ macrophages overcomes resistance to immune checkpoint inhibitors in melanoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Xinyu","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"10400","key":"2444_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet (London England). 2023;402(10400):485\u2013502. https:\/\/doi.org\/10.1016\/s0140-6736(23)00821-8.","journal-title":"Lancet (London England)"},{"issue":"10304","key":"2444_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/s0140-6736(21)01206-x","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet (London England). 2021;398(10304):1002\u201314. https:\/\/doi.org\/10.1016\/s0140-6736(21)01206-x.","journal-title":"Lancet (London England)"},{"key":"2444_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102499","volume":"113","author":"DC Ziogas","year":"2023","unstructured":"Ziogas DC, Theocharopoulos C, Koutouratsas T, Haanen J, Gogas H. Mechanisms of resistance to immune checkpoint inhibitors in melanoma: what we have to overcome? Cancer Treat Rev. 2023;113:102499. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102499.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2444_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01043-6","volume":"7","author":"Y Li","year":"2024","unstructured":"Li Y, Wu X, Fang D, Luo Y. Informing immunotherapy with multi-omics driven machine learning. NPJ Digit Med. 2024;7(1):67. https:\/\/doi.org\/10.1038\/s41746-024-01043-6.","journal-title":"NPJ Digit Med"},{"key":"2444_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063563","author":"C Donisi","year":"2024","unstructured":"Donisi C, Pretta A, Pusceddu V, Ziranu P, Lai E, Puzzoni M, et al. Immunotherapy and cancer: the multi-omics perspective. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063563.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"2444_CR6","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2021;184(21):5309\u201337. https:\/\/doi.org\/10.1016\/j.cell.2021.09.020.","journal-title":"Cell"},{"issue":"9","key":"2444_CR7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41590-023-01578-y","volume":"24","author":"MW Rudloff","year":"2023","unstructured":"Rudloff MW, Zumbo P, Favret NR, Roetman JJ, Detr\u00e9s Rom\u00e1n CR, Erwin MM, et al. Hallmarks of CD8(+) T cell dysfunction are established within hours of tumor antigen encounter before cell division. Nat Immunol. 2023;24(9):1527\u201339. https:\/\/doi.org\/10.1038\/s41590-023-01578-y.","journal-title":"Nat Immunol"},{"issue":"6","key":"2444_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","volume":"35","author":"D Dangaj","year":"2019","unstructured":"Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, et al. Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Cancer Cell. 2019;35(6):885\u2013e90010. https:\/\/doi.org\/10.1016\/j.ccell.2019.05.004.","journal-title":"Cancer Cell"},{"issue":"8","key":"2444_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2444_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten K, Hu KH, Combes AJ, Samad B, Harwin T, Ray A, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer. Cancer Cell. 2022;40(6):624\u2013e389. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.004.","journal-title":"Cancer Cell"},{"issue":"12","key":"2444_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1136\/gutjnl-2022-329147","volume":"72","author":"Y Li","year":"2023","unstructured":"Li Y, Shen Z, Chai Z, Zhan Y, Zhang Y, Liu Z, et al. Targeting MS4A4A on tumour-associated macrophages restores CD8\u2009+\u2009t-cell-mediated antitumour immunity. Gut. 2023;72(12):2307\u201320. https:\/\/doi.org\/10.1136\/gutjnl-2022-329147.","journal-title":"Gut"},{"issue":"1","key":"2444_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03856-z","volume":"21","author":"R Huang","year":"2023","unstructured":"Huang R, Shen G, Ren Y, Zheng K, Wang J, Shi Y, et al. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma. J Transl Med. 2023;21(1):78. https:\/\/doi.org\/10.1186\/s12967-022-03856-z.","journal-title":"J Transl Med"},{"issue":"7446","key":"2444_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445\u201355. https:\/\/doi.org\/10.1038\/nature12034.","journal-title":"Nature"},{"issue":"3","key":"2444_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792\u2013e80923. https:\/\/doi.org\/10.1016\/j.cell.2021.01.010.","journal-title":"Cell"},{"issue":"4","key":"2444_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78(4):770\u201382. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.011.","journal-title":"J Hepatol"},{"key":"2444_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216568","volume":"582","author":"L Ding","year":"2024","unstructured":"Ding L, Qian J, Yu X, Wu Q, Mao J, Liu X, et al. Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway. Cancer Lett. 2024;582:216568. https:\/\/doi.org\/10.1016\/j.canlet.2023.216568.","journal-title":"Cancer Lett"},{"issue":"2","key":"2444_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","volume":"24","author":"S Ma","year":"2023","unstructured":"Ma S, Sun B, Duan S, Han J, Barr T, Zhang J, et al. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8(+) T cells. Nat Immunol. 2023;24(2):255\u201366. https:\/\/doi.org\/10.1038\/s41590-022-01398-6.","journal-title":"Nat Immunol"},{"issue":"7","key":"2444_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","volume":"39","author":"A Chow","year":"2021","unstructured":"Chow A, Schad S, Green MD, Hellmann MD, Allaj V, Ceglia N, et al. Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity. Cancer Cell. 2021;39(7):973\u2013e889. https:\/\/doi.org\/10.1016\/j.ccell.2021.05.006.","journal-title":"Cancer Cell"},{"issue":"1","key":"2444_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel TR, Lill JK, Altenburger LM. How chemokines organize the tumour microenvironment. Nat Rev Cancer. 2024;24(1):28\u201350. https:\/\/doi.org\/10.1038\/s41568-023-00635-w.","journal-title":"Nat Rev Cancer"},{"issue":"7269","key":"2444_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108\u201312. https:\/\/doi.org\/10.1038\/nature08460.","journal-title":"Nature"},{"issue":"43","key":"2444_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"2444_CR22","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1158\/1078-0432.ccr-12-3776","volume":"19","author":"C Marin-Muller","year":"2013","unstructured":"Marin-Muller C, Li D, Bharadwaj U, Li M, Chen C, Hodges SE, et al. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res. 2013;19(21):5901\u201313. https:\/\/doi.org\/10.1158\/1078-0432.ccr-12-3776.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2444_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman M, Yizhak K, Bjorgaard SL, Ray JP, de Boer CG, Jenkins RW, et al. Defining T cell States associated with response to checkpoint immunotherapy in melanoma. Cell. 2018;175(4):998\u2013e101320. https:\/\/doi.org\/10.1016\/j.cell.2018.10.038.","journal-title":"Cell"},{"issue":"1","key":"2444_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35\u201344. https:\/\/doi.org\/10.1016\/j.cell.2016.02.065.","journal-title":"Cell"},{"issue":"10","key":"2444_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med. 2018;24(10):1545\u20139. https:\/\/doi.org\/10.1038\/s41591-018-0157-9.","journal-title":"Nat Med"},{"issue":"9","key":"2444_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2174\/1389557054867057","volume":"5","author":"R Horuk","year":"2005","unstructured":"Horuk R. BX471: a CCR1 antagonist with anti-inflammatory activity in man. Mini Rev Med Chem. 2005;5(9):791\u2013804. https:\/\/doi.org\/10.2174\/1389557054867057.","journal-title":"Mini Rev Med Chem"},{"key":"2444_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155758","volume":"151","author":"H Li","year":"2024","unstructured":"Li H, Pan T, Gao L, Ding R, Yu Y, Ma M, et al. Chemokine receptor CCR1 regulates macrophage activation through mTORC1 signaling in nonalcoholic steatohepatitis. Metabolism. 2024;151:155758. https:\/\/doi.org\/10.1016\/j.metabol.2023.155758.","journal-title":"Metabolism"},{"issue":"6","key":"2444_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","volume":"40","author":"K Kersten","year":"2022","unstructured":"Kersten K, Hu KH, Combes AJ, Samad B, Harwin T, Ray A, et al. Spatiotemporal co-dependency between macrophages and exhausted CD8\u2009+\u2009t cells in cancer. Cancer Cell. 2022;40(6):624. https:\/\/doi.org\/10.1016\/j.ccell.2022.05.004.","journal-title":"Cancer Cell"},{"issue":"6","key":"2444_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n D, S\u00e1nchez-Madrid F. CD69: from activation marker to metabolic gatekeeper. Eur J Immunol. 2017;47(6):946\u201353. https:\/\/doi.org\/10.1002\/eji.201646837.","journal-title":"Eur J Immunol"},{"issue":"12","key":"2444_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0167-5699(89)90040-6","volume":"10","author":"BF Haynes","year":"1989","unstructured":"Haynes BF, Telen MJ, Hale LP, Denning SM. CD44\u2013a molecule involved in leukocyte adherence and T-cell activation. Immunol Today. 1989;10(12):423\u20138. https:\/\/doi.org\/10.1016\/0167-5699(89)90040-6.","journal-title":"Immunol Today"},{"issue":"6","key":"2444_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ccell.2024.04.011","volume":"42","author":"MJ van Elsas","year":"2024","unstructured":"van Elsas MJ, Middelburg J, Labrie C, Roelands J, Schaap G, Sluijter M, et al. Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy. Cancer Cell. 2024;42(6):1032\u2013e5010. https:\/\/doi.org\/10.1016\/j.ccell.2024.04.011.","journal-title":"Cancer Cell"},{"key":"2444_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006808","author":"J Xu","year":"2023","unstructured":"Xu J, Shi Q, Lou J, Wang B, Wang W, Niu J, et al. Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-006808.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"2444_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19(6):402\u201321. https:\/\/doi.org\/10.1038\/s41571-022-00620-6.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"2444_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369\u201382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6.","journal-title":"Nat Rev Immunol"},{"issue":"7355","key":"2444_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222\u20135. https:\/\/doi.org\/10.1038\/nature10138.","journal-title":"Nature"},{"issue":"1","key":"2444_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s1074-7613(03)00174-2","volume":"19","author":"F Geissmann","year":"2003","unstructured":"Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71\u201382. https:\/\/doi.org\/10.1016\/s1074-7613(03)00174-2.","journal-title":"Immunity"},{"key":"2444_CR37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72418","author":"L Medina-Ruiz","year":"2022","unstructured":"Medina-Ruiz L, Bartolini R, Wilson GJ, Dyer DP, Vidler F, Hughes CE, et al. Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice. eLife. 2022. https:\/\/doi.org\/10.7554\/eLife.72418.","journal-title":"eLife"},{"issue":"11","key":"2444_CR38","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","volume":"55","author":"BG Nixon","year":"2022","unstructured":"Nixon BG, Kuo F, Ji L, Liu M, Capistrano K, Do M, et al. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity. 2022;55(11):2044\u2013e585. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.002.","journal-title":"Immunity"},{"issue":"33","key":"2444_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309885","volume":"11","author":"Z Xun","year":"2024","unstructured":"Xun Z, Zhou H, Shen M, Liu Y, Sun C, Du Y, et al. Identification of hypoxia-ALCAM(high) macrophage- exhausted T cell axis in tumor microenvironment remodeling for immunotherapy resistance. Adv Sci. 2024;e2309885. https:\/\/doi.org\/10.1002\/advs.202309885.","journal-title":"Adv Sci"},{"issue":"5","key":"2444_CR40","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/hep.23338","volume":"50","author":"GA Ramm","year":"2009","unstructured":"Ramm GA. Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease. Hepatology (Baltimore MD). 2009;50(5):1664\u20138. https:\/\/doi.org\/10.1002\/hep.23338.","journal-title":"Hepatology (Baltimore MD)"},{"key":"2444_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56554","author":"JL Galeano Ni\u00f1o","year":"2020","unstructured":"Galeano Ni\u00f1o JL, Pageon SV, Tay SS, Colakoglu F, Kempe D, Hywood J, et al. Cytotoxic t cells swarm by homotypic chemokine signalling. eLife. 2020. https:\/\/doi.org\/10.7554\/eLife.56554.","journal-title":"eLife"},{"issue":"1","key":"2444_CR42","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1038\/s41467-021-25282-3","volume":"12","author":"B Weigelin","year":"2021","unstructured":"Weigelin B, den Boer AT, Wagena E, Broen K, Dolstra H, de Boer RJ, et al. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun. 2021;12(1):5217. https:\/\/doi.org\/10.1038\/s41467-021-25282-3.","journal-title":"Nat Commun"},{"issue":"2","key":"2444_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/84205","volume":"2","author":"SA Luther","year":"2001","unstructured":"Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2(2):102\u20137. https:\/\/doi.org\/10.1038\/84205.","journal-title":"Nat Immunol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02444-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:48:45Z","timestamp":1762166925000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02444-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2444"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02444-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}